These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1291 related items for PubMed ID: 16427802

  • 1. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK, Dockter J, Linnen JM, Kolk D, Wu Y, Giachetti C.
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [Abstract] [Full Text] [Related]

  • 2. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A, Moschidis Z, Sypsa V, Chini M, Papatheodoridis GV, Tassopoulos NC, Mimidis K, Karafoulidou A, Hatzakis A.
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [Abstract] [Full Text] [Related]

  • 3. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH, Assal A, Chudy M, Torres P, de Villaescusa RG, Reesink HW, Lelie PN, Cuypers HT.
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [Abstract] [Full Text] [Related]

  • 4. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.
    Xiao X, Zhai J, Zeng J, Tian C, Wu H, Yu Y.
    J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222
    [Abstract] [Full Text] [Related]

  • 5. Neopterin levels during the early phase of human immunodeficiency virus, hepatitis C virus, or hepatitis B virus infection.
    Nübling CM, Chudy M, Volkers P, Löwer J.
    Transfusion; 2006 Nov; 46(11):1886-91. PubMed ID: 17076842
    [Abstract] [Full Text] [Related]

  • 6. Automated multiplex assay system for simultaneous detection of hepatitis B virus DNA, hepatitis C virus RNA, and human immunodeficiency virus type 1 RNA.
    Meng Q, Wong C, Rangachari A, Tamatsukuri S, Sasaki M, Fiss E, Cheng L, Ramankutty T, Clarke D, Yawata H, Sakakura Y, Hirose T, Impraim C.
    J Clin Microbiol; 2001 Aug; 39(8):2937-45. PubMed ID: 11474017
    [Abstract] [Full Text] [Related]

  • 7. Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.
    Margaritis AR, Brown SM, Seed CR, Kiely P, D'Agostino B, Keller AJ.
    Transfusion; 2007 Oct; 47(10):1783-93. PubMed ID: 17880602
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.
    Nantachit N, Thaikruea L, Thongsawat S, Leetrakool N, Fongsatikul L, Sompan P, Fong YL, Nichols D, Ziermann R, Ness P, Nelson KE.
    Transfusion; 2007 Oct; 47(10):1803-8. PubMed ID: 17880604
    [Abstract] [Full Text] [Related]

  • 9. Sensitivity of two hepatitis B virus, hepatitis C virus (HCV), and human immunodeficiency virus (HIV) nucleic acid test systems relative to hepatitis B surface antigen, anti-HCV, anti-HIV, and p24/anti-HIV combination assays in seroconversion panels.
    Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, van Drimmelen H, David B, Lelie N, De Micco P.
    Transfusion; 2009 Feb; 49(2):301-10. PubMed ID: 19389212
    [Abstract] [Full Text] [Related]

  • 10. Effect of viral nucleic acid testing on contamination frequency of manufacturing plasma pools.
    Nübling CM, Unkelbach U, Chudy M, Seitz R.
    Transfusion; 2008 May; 48(5):822-6. PubMed ID: 18208414
    [Abstract] [Full Text] [Related]

  • 11. The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan.
    Yang MH, Li L, Hung YS, Hung CS, Allain JP, Lin KS, Tsai SJ.
    Transfusion; 2010 Jan; 50(1):65-74. PubMed ID: 19709394
    [Abstract] [Full Text] [Related]

  • 12. One-year experience of nucleic acid technology testing for human immunodeficiency virus Type 1, hepatitis C virus, and hepatitis B virus in Thai blood donations.
    Phikulsod S, Oota S, Tirawatnapong T, Sakuldamrongpanich T, Chalermchan W, Louisirirotchanakul S, Tanprasert S, Chongkolwatana V, Kitpoka P, Phanuphak P, Wasi C, Nuchprayoon C, Working Group for NAT Study in Thai Blood Donations.
    Transfusion; 2009 Jun; 49(6):1126-35. PubMed ID: 19392770
    [Abstract] [Full Text] [Related]

  • 13. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
    Vermeulen M, Lelie N, Sykes W, Crookes R, Swanevelder J, Gaggia L, Le Roux M, Kuun E, Gulube S, Reddy R.
    Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A, Barlet V, Deschaseaux M, Dupont I, Gallian P, Guitton C, Morel P, David B, De Micco P.
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [Abstract] [Full Text] [Related]

  • 15. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
    Li L, Chen PJ, Chen MH, Chak KF, Lin KS, Tsai SJ.
    Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
    [Abstract] [Full Text] [Related]

  • 16. HIV-1, HCV and HBV seronegative window reduction by the new Roche cobas TaqScreen MPX test in seroconverting donors.
    Wiedmann M, Kluwick S, Walter M, Fauchald G, Howe J, Bronold M, Zauke M.
    J Clin Virol; 2007 Aug; 39(4):282-7. PubMed ID: 17611148
    [Abstract] [Full Text] [Related]

  • 17. Multiplex real-time quantitative RT-PCR assay for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus type 1.
    Candotti D, Temple J, Owusu-Ofori S, Allain JP.
    J Virol Methods; 2004 Jun 01; 118(1):39-47. PubMed ID: 15158067
    [Abstract] [Full Text] [Related]

  • 18. [Evaluation of procleix HIV/HCV RNA diagnostic assay].
    Song AJ, Zhang CT, Li XH, Li J, Wang YC.
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar 01; 20(1):36-8. PubMed ID: 16642216
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.
    Koppelman MH, Sjerps MC, Reesink HW, Cuypers HT.
    Vox Sang; 2005 Nov 01; 89(4):193-200. PubMed ID: 16262751
    [Abstract] [Full Text] [Related]

  • 20. Analytical and clinical performance evaluation of the cobas TaqScreen MPX Test for use on the cobas s 201 system.
    Ohhashi Y, Pai A, Halait H, Ziermann R.
    J Virol Methods; 2010 May 01; 165(2):246-53. PubMed ID: 20152864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 65.